Pediatrix Medical Group (MD) Competitors $15.57 -1.66 (-9.64%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$15.59 +0.02 (+0.13%) As of 02/21/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MD vs. AMED, AMN, CCRN, LH, DGX, DVA, CHE, CRVL, SEM, and EHCShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Select Medical (SEM), and Encompass Health (EHC). Pediatrix Medical Group vs. Amedisys AMN Healthcare Services Cross Country Healthcare Laboratory Co. of America Quest Diagnostics DaVita Chemed CorVel Select Medical Encompass Health Pediatrix Medical Group (NYSE:MD) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends. Is MD or AMED more profitable? Amedisys has a net margin of 3.57% compared to Pediatrix Medical Group's net margin of -4.92%. Pediatrix Medical Group's return on equity of 15.47% beat Amedisys' return on equity.Company Net Margins Return on Equity Return on Assets Pediatrix Medical Group-4.92% 15.47% 5.64% Amedisys 3.57%12.20%6.74% Do insiders and institutionals hold more shares of MD or AMED? 97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 94.4% of Amedisys shares are owned by institutional investors. 2.0% of Pediatrix Medical Group shares are owned by insiders. Comparatively, 2.1% of Amedisys shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, MD or AMED? Pediatrix Medical Group has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Does the MarketBeat Community prefer MD or AMED? Pediatrix Medical Group received 12 more outperform votes than Amedisys when rated by MarketBeat users. Likewise, 60.21% of users gave Pediatrix Medical Group an outperform vote while only 58.65% of users gave Amedisys an outperform vote. CompanyUnderperformOutperformPediatrix Medical GroupOutperform Votes50760.21% Underperform Votes33539.79% AmedisysOutperform Votes49558.65% Underperform Votes34941.35% Do analysts prefer MD or AMED? Pediatrix Medical Group presently has a consensus target price of $17.08, indicating a potential upside of 9.73%. Amedisys has a consensus target price of $100.75, indicating a potential upside of 11.41%. Given Amedisys' higher possible upside, analysts clearly believe Amedisys is more favorable than Pediatrix Medical Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Amedisys 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 Which has better earnings & valuation, MD or AMED? Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPediatrix Medical Group$2.01B0.66-$60.41M-$1.20-12.97Amedisys$2.24B1.32-$9.75M$2.5235.88 Does the media prefer MD or AMED? In the previous week, Pediatrix Medical Group had 8 more articles in the media than Amedisys. MarketBeat recorded 18 mentions for Pediatrix Medical Group and 10 mentions for Amedisys. Pediatrix Medical Group's average media sentiment score of 0.77 beat Amedisys' score of 0.39 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 5 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Amedisys 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryPediatrix Medical Group beats Amedisys on 9 of the 17 factors compared between the two stocks. Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupHospitals IndustryMedical SectorNYSE ExchangeMarket Cap$1.48B$4.67B$5.84B$20.27BDividend YieldN/A1.65%4.76%3.64%P/E RatioN/A8.1318.2629.78Price / Sales0.660.98434.4715.49Price / Cash4.917.7938.4220.54Price / Book1.752.247.644.90Net Income-$60.41M$212.93M$3.18B$1.02B7 Day Performance10.72%0.70%-1.95%-1.05%1 Month Performance10.61%1.70%-0.23%-1.09%1 Year Performance81.46%26.92%16.69%13.70% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group1.0205 of 5 stars$15.57-9.6%$17.08+9.7%+79.9%$1.48B$2.01B-12.975,170Earnings ReportAnalyst ForecastNews CoverageHigh Trading VolumeAMEDAmedisys3.4841 of 5 stars$92.60-0.2%$100.75+8.8%-3.4%$3.03B$2.24B36.7519,000News CoverageAMNAMN Healthcare Services4.1304 of 5 stars$23.40+0.1%$44.50+90.2%-53.5%$890.69M$3.79B16.953,585Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading VolumeCCRNCross Country Healthcare3.4069 of 5 stars$18.15-0.3%$18.54+2.1%+6.3%$595.68M$2.02B-362.9310,831LHLaboratory Co. of America4.7851 of 5 stars$246.74+0.8%$265.31+7.5%+14.7%$20.64B$13.01B27.9867,000Positive NewsDGXQuest Diagnostics4.7539 of 5 stars$168.97+0.1%$177.69+5.2%+36.1%$18.86B$9.87B21.9748,000Insider TradeAnalyst RevisionPositive NewsDVADaVita4.3966 of 5 stars$156.95-11.4%$161.80+3.1%+17.7%$12.87B$12.14B16.9370,000Analyst ForecastHigh Trading VolumeCHEChemed4.7405 of 5 stars$553.10-1.3%$641.50+16.0%-7.4%$8.32B$2.38B27.9515,087Upcoming EarningsDividend AnnouncementPositive NewsCRVLCorVel1.2282 of 5 stars$117.33-1.5%N/A+24.8%$5.98B$795.31M69.024,870Analyst DowngradeInsider TradeSEMSelect Medical4.9817 of 5 stars$18.58-0.9%$39.50+112.6%-34.0%$2.41B$6.97B8.6854,600Earnings ReportAnalyst UpgradeNews CoverageGap DownEHCEncompass Health4.7632 of 5 stars$100.91+0.8%$107.67+6.7%+30.7%$10.17B$5.37B22.6238,000Dividend AnnouncementAnalyst RevisionPositive News Related Companies and Tools Related Companies AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors CRVL Competitors SEM Competitors EHC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:MD) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
